Global Clostridium Diagnostics Market is valued at approximately USD 838.05 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.10% over the forecast period 2023-2030.
Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.
The findings show a complex intercontinental transport route for microbes like E. coli, Staphylococcus saprophyticus, and Clostridium difficile, protected from ultraviolet light and dehydration by ...